mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.009 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |